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CHAPTER 1 
INTRODUCTION 
 Nutrigenomics is becoming a rising field of study for nutritionists and 
molecular biologists to better understand the interaction of food and nutrients on 
the human genome. The main approach to such concerns is to closely observe 
how the diet modifies the gene expressions that control several cellular 
processes in the human body. Epidemiologic studies imply an inverse correlation 
between the intake of dietary folate and the risks of numerous melanomas 
including cancer of the liver, stomach, pancreas, colon, and the breast [1]. The 
exact impact of folate status on the development of these tumors in different 
body organs has not yet been well established [1]. However, a diet that is 
deficient in folate has shown to induce carcinogenesis by affecting the base 
excision repair homeostasis. Hence, it is important to understand the mechanism 
behind folate deficiency and the development of cancer.   
A. Folate  
 Folate is an essential water-soluble vitamin that is involved in several 
mechanisms and pathways in relevance to the etiologies of birth defects and 
chronic diseases. Despite the fact that this vitamin is widely available in plant 
based food, it is often found to be under-consumed by individuals whose dietary 
habits emphasize on fast food and diets low in fruits and vegetables [2]. Folate is 
used as the generic term for the bioactive forms of the fundamental B vitamins 
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found in our diet [3]. These forms include the folate that is naturally available in 
food “pterolypolyglutamates”, and the folic acid that is used in vitamin 
supplements and fortified food products “monoglutamate folic acid” [3]. Folic acid 
has a crucial role in acting as a coenzyme in the metabolism of amino acids and 
nucleic acids. This vitamin is essential to maintain a normal cell division and is 
most important throughout early stages of development and growth [3]. This is 
the reason why the US and Canadian governments intervened more than a 
decade ago and applied obligatory folic acid fortification of most grains and 
cereal products to ensure adequate consumption of this vitamin.  
B. Folic Acid Food Fortification and Neural Tube Defects 
 Neural tube defects (NTDs) are birth defects of the brain and/or the spinal 
cord that occur very early in embryonic development. This phenomenon occurs 
when the neural tube fails to close during the early stages of embryonic 
development which results in the destruction of the neural tissues [4]. Poor folate 
status is known to cause NTDs, miscarriages, and premature births. Therefore, 
women in a child bearing age are encouraged to consume a supplement 
containing 400 micrograms of folic acid daily. However, in the United States, 
almost more that 50% of all pregnancies are unplanned pregnancy which 
increases the chance of developing birth defects [4].  
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C. Concerns about Potential Adverse Effects 
 It is true that there are always serious concerns regarding potential 
adverse effects after implementing any intervention that targets the public health. 
Some of these concerns are: 
1. Masking of B12 Deficiency Anemia 
 Certain concerns have been indicating that it is possible for folic acid to 
cause the masking of anemia related to vitamin B12 deficiency. Previous studies 
have shown that consuming daily supplements high in folic acid (>5000 
micrograms) could actually prevent the development of anemia that is caused by 
vitamin B12 deficiency. This vitamin B12 deficiency, if not detected at an early 
stage, could cause the progression of serious deficiency-related neuropathies [4].  
2. Cancer and Epigenetic Changes  
 There has been a strong correlation between folate status and cancer 
development. Studies have shown that consuming a diet high in fruits and 
vegetables could possibly decrease the risks of developing many types of 
cancer. Based on this assumption, studies are being conducted to determine the 
mechanism behind the impact of folic acid on the changes in epigenetic patterns. 
Folate is being involved as a one-carbon methyl group donor in two basic 
metabolic pathways, the DNA synthesis and the DNA methylation [4]. This critical 
role suggests that folic acid could be preventing some cancers or could be 
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inducing other neoplasias. It has been believed that the adequate consumption of 
folic acid may prevent the development of tumor cells by providing enough 
methyl groups to enhance DNA repair when damage occurs. Whereas, some 
studies have shown that high consumption of folic acid actually advances the 
further development of pre-existing tumors. However, further studies should be 
conducted to better understand the effect of folic acid on epigenetics [4]. 
D. Folate in One-Carborn Metabolism 
 As discussed earlier, folate is an essential vitamin that is involved in 
multiple cellular functions such as cell division, DNA repair, and the regulation of 
the amino acid homocysteine [5]. It is important to understand how the folic acid 
status alters the one-carbon mechanism. 5-methylenetetrahydrofolate (5-methyl 
THF) is one of the main factors involved in the one-carbon metabolism. The 
enzyme methylenetetrahydrofolate reductase (MTHER) is responsible for 
irreversibly converting 5,10-methylene TFH into 5-methyl THF (figure 1-1).  The 
most important functions that are involved in the folate metabolism are: the 
transfer of one carbon in the methionine cycle, the synthesis of thymidylate and 
purines (adenine and guanine), and the methylation reactions of the DNA. In the 
methionine cycle, 5-methyl THF is responsible for the remethylation of 
homocysteine to methionine. This produced methionine is then broken down to s-
adenosylmethionine (SAM) which is considered a methyl group donor [5,6].  
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Moreover, since the 5-methyl THF is being used as the main methyl donor in the 
cycle, the levels of the adenodine and the guanosine remain relatively sufficient 
[5]. Furthermore, thymidine is generated by the conversion of deoxyuridine 
monophosphate (dUMP) into thymidine monophosphate (TMP) during the 
pyrimidine biosynthesis pathway, with the help of the enzyme thymidylate 
synthase (TS) [5,6]. These reactions are required in order to be able to sustain 
proper DNA proliferation and repair when damage persists. However, this 
pathway is altered when folate is deficient, which can cause severe threats on 
the health of the population [5]. 
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E. Sources of DNA Damage   
 Maintaining the integrity of the genomic material in the nucleus of the cells 
is a fundamental necessity for existence and survival. Failure to conserve the 
genetic information would result in cellular failure or in the constant inheritance of 
incorrect and mutated information. This has a massive effect mainly on the 
metabolism and the proliferation of the cell which in turn can cause cancer and 
tumors.  It is interesting to assume that the reason behind the minimal mutation 
rates in the mammalian cells is the stability of inherited genome. But it is not 
actually the case. The DNA in the cell is being exposed to continuous insults 
from different sources which as a result alter its stability and integrity. Hence, the 
cell undergoes certain repair actions to eliminate the damage and conserve its 
information [7]. 
 The human genetic material is highly susceptible to a vast variety of 
insults, including important spontaneous damages such as: hydrolytic decay of 
DNA, damage from oxidative stress as a result of cellular production of reactive 
oxygen species (ROS), defects from the metabolism of the nucleic acid which 
introduces errors during DNA replication, or even from environmental agents 
such as the exposure to UV light, toxic chemicals and radiation [7]. 
1. Hydrolytic Damage of DNA: 
 It is true that the DNA phosphodiester bonds are quite more stable than 
those of the RNA, but the removal of the hydroxyl group on the 2’ sugar carbon in 
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the DNA destabilizes the N-glycosyl bond, which links the base with the sugar. 
Hence, the hydrolysis of the N-glycosyl bond leads to the actual loss of the 
bases. Moreover, the deamination of the bases of the DNA, such as the cytosine 
and 5- methylcytosine residues, is also another form of hydrolytic damage. Uracil 
is produced as a result of the deamination of cytosine which is later detected by 
the specific repair enzyme UDG and becomes repaired. Whereas, the normal 
DNA nucleotide, thymine, is produced as a result of the deamination of 5- 
methylcytosine, where G:U mispair sites are being repaired more efficiently than 
the G:T mispair sites. Hence, mutations occur more frequently with 5- 
methylcytosine residues [7]. 
2. Formation of Reactive Derivatives of Oxygen: 
 The unwanted elevated levels of reactive oxygen species (ROS) and the 
reduced production of antioxidants cause oxidative stress. Oxidants are elevated 
as a result of typical metabolic reactions such as: the mitochondrial electron 
transport, diverse oxygen-utilizing enzyme systems, and peroxisome function, 
which may be produced by phagocytic cells or formed from the peroxidation of 
lipids. The lipid peroxidation would damage the mitochondria that have 
cardiolipin, which activates cytochrome-c oxidas, in its inner membrane structure, 
whereas the protein oxidation affects the respiratory chain enzymes as well as 
ATPases [8]. The production of the ROS is also mainly due to the consumption of 
oxygen by the aerobic respiration for the oxidation of electron carriers. This 
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oxidation process converts oxygen (O2) into superoxide anion (O2
-) and produces 
H2O as well, which is not quite reactive itself. But the availability of the OH 
hydroxyl group would undergo oxidation reaction with reduced transition metals 
such as Fe2+[7]. These oxidative damages to DNA, RNA, proteins, and lipids will 
in turn damage the cell and cause cancer and early aging. Usually young cells 
have lower levels of ROS than older cells. These levels, if present at a very high 
rate would actually induce the cells to go to an earlier senescence [8].  Hence, 
any modification in the ROS equilibrium within a cell would prevent or restore 
cellular senescence. [9]  
F. Repair Mechanisms 
 It is very important for such errors to be repaired immediately in order to 
prevent some irreversible changes or even the complete loss of the genetic 
material within the cell. The DNA response is a complex network of signaling 
pathways which is important for the protection of the genome. Upon detection of 
DNA damage, the cell has its own repair mechanisms that are involved in fixing 
the lesions. Some of these mechanisms are, base excision repair (BER), 
nucleotide excision repair (NER), and mismatch repair (MMR) [10]. 
1. Base Excision Repair  
 The specific pathway of the BER from bacterial cells to humans involves a 
number of coordinated steps. (1) Excision of a modified or altered base; (2) 
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cleavage of the generated AP site; (3) processing of the blocking termini at the 
break site; (4) repair synthesis; (5) ligation of the broken strands [11]. 
 The first step in the BER pathway (figure 1-2) is catalyzed by DNA 
glycosylases that recognize the damaged or abnormal base in the DNA strand.  
Two types from the glycosylase enzymatic family are present with different 
catalytical mechanisms depending whether they have an associated AP lyase 
activity or not [11].  
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Monofunctional DNA glycosylases actually hydrolyze the N-C1’ glycosyl bond 
that is present between the specific base of interest and the sugar molecule 
which eventually leads to the generation of an AP site. Whereas the bifunctional 
DNA glycosylases excise the base of interest and then cleave the 
phosphodiester bonds 3’ to an AP site by the action of AP lyase. This generates     
3’-OH and 5’ deoxyribose phosphate end of the strand break and leaves a single 
nucleotide gap. However, this gap is filled by a new specific nucleotide with the 
action of DNA polymerase and then sealed by the DNA ligase enzymes. 
Biochemical evidence has shown at least two important subpathways in this BER 
mechanism: the short-patch (one nucleotide) and the long-patch (more than one 
base). They both differ in the repair patch size as well as the enzymes involved in 
the process [11]. 
2. Nucleotide Excision Repair  
 The double stranded helix of the DNA is very important in the repairing 
process since such mechanism takes advantage of the other strand that carries 
the correct DNA sequence and aid in placing a complimentary base instead of 
the abnormal one that has to be excised. This NER repair mechanism is done via 
five steps. In step 1, the helicase enzyme is responsible for the unwinding of the 
double stranded DNA helix which forms a bubble site for the repair to take place. 
In step 2, an endonucleolyic activity is required for this step to form a first incision 
that takes place approximately six bases downstream of the lesion site. In step 3, 
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another endonuclease enzyme is required in this step to form a second incision 
that occurs approximately 22 bases upstream of the lesion site. By inserting 
these two incision sites to the damage-containing oligonucleotide, leaves it 
unlinked to the chromosomal DNA but still attached to the genome only through 
its base-paring hydrogen bonds. In step 4, helicase enzyme removes the 
damage-containing oligonucleotide which results in forming a gap repair 
intermediate. Finally in step 5, the following gap is then all filled up by the DNA 
synthesis complex which uses the second normal strand of the DNA as the right 
template [11]. 
G. DNA Polymerases 
 In order to maintain life and survival, the genomic stability and consistency 
is a must throughout the cell replications. Prior to cell division in eukaryotic cells, 
the replication process of DNA must be able to conserve and accurately 
duplicate the whole entire bases with minimal to error-free procedure. [12] In fact, 
the DNA is never stable for it is frequently exposed to endogenous as well as 
exogenous factors that alter its stability. A while ago, scientists have predicted 
that eukaryotic genome is continuously encountering more than 100,000 
modifications on a daily basis.  To overcome such life threatening modifications, 
spontaneous repair mechanisms take place to conserve the DNA sequence as 
well as its structure [12]. DNA replication is performed by a complex of enzymes 
called DNA polymerases such as α, β and γ DNA polymerase [13]. In general, 
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the DNA polymerizing process is frequently coupled with a proof-reading 
3′→5′ exonuclease activity which directly eliminates any errors. In addition to 
that, the DNA polymerase family also plays important roles in the activity of the 
DNA primase and in the interaction with several proteins that are known to be 
implicated in the DNA replications, repair actions, cell cycle control as well in 
checkpoint functions [12]. Each one of the polymerases is more or less specific 
to a given process. 
H. DNA Replication 
 DNA replication is a complex process that requires the incorporation of 
multiple specific enzymes and proteins to do the job. Some of these involved are 
DNA polymerases α, δ, and ε, DNA primase, topoisomerases I and II, the 
replication protein A (RPA), the replication factor C, the poly (ADP) ribose 
polymeras, as well as a DNA helicase and ligase. It is understood that 
βpolymerase is responsible for the action of gap filling which links with the 
replication of the DNA [14]. At fork replication site, the fusion of the 
discontinuously formed Okazaki fragments forms the lagging strand of the DNA. 
Then, the RNases H confiscate the RNA primers that were still attached to the 
end side of the Okazaki fragments. Finally, the Ligase enzymes proceed with the 
ligation process and join the fragments together to complete the DNA synthesis 
[14]. 
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I. Specific Roles of DNA βpolymerase 
 In our lab we are more interested in the βpolymerase as it contributes 
primarly in the DNA repair process. In normal scenarios, the βpolymerase are 
normally expressed at stable but low levels all the way through the cell cycle and 
are usually influenced by many genotoxic treatments [14]. What actually 
discriminate βpolymerase from all the rest are the following unique features: the 
absence of the linked proofreading action, the dishonesty in replicating DNA in 
vitro, as well as the inability to differentiate bases at the level of binding. 
However, the accuracy of the βpolymerase is known to be increased upon the 
incorporation of a single nucleotide.  A lot of recent studies show that excess 
expression of βpolymerase would lead to the disturbance of the error-free 
mechanism theory which showed an increase in spontaneous mutagenesis and 
apoptosis due to the development of tumors in the cells [14]. 
 J. βPolymerase and Repair Pathways Involving Gapped DNA 
 The three main types of DNA repair in the eukaryotic cells are BER, NER, 
and MMR. These repair processes actually produce nucleotide breaks and gaps 
that must be refilled again by the multiple actions of the DNA polymerases. The 
NER process eliminates the DNA lesions that are responsible for the DNA double 
helix deformations. Such pathway develops the damage by spotting these 
lesions, eliminating the part that is holding the modified nucleotides, and finally 
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synthesizing the right complementary nucleotides from the other strand using it 
as a template. Hence, the sensitivity and the precision of these DNA 
polymerases perfectly synthesize the DNA without any errors, which reveals the 
stability of the genes by inserting the correct complementary base in the right 
place [14]. The βpolymerase plays an important role in the base excision repair 
pathway where the DNA damages as well as the DNA adducts are being 
corrected in this process [15]. βpolymerase play important roles in both: the 
short patch and the long patch of the BER [16]. The actions of the polymerase 
and the lyase allow the βpolymerase to be engaged in two main steps in the 
“short-patch” BER pathway. These steps are the removal of 5′-deoxyribose 
phosphate intermediate and then managing to fill the 1 nucleotide gap that had 
been produced [15]. βpolymerase is also involved in the “long-patch” BER which 
fills the gaps of a number of nucleotides in a DNA [14]. It has been believed that 
the effectiveness of βpolymerase is 800-10000 folds higher on 1- nucleotide 
DNA gap than on any other substrates. Hence, βpolymerase are more 
consistent and precise in the short patch base excision repair [14]. In this 
pathway, the glycosidic bond that connects to the unwanted damaged nucleotide 
is being sliced up by the DNA glycosylase which in turn gets rid of the ruined 
base to produce an AP site in the DNA double strand [13]. Moreover, the 
phosphodiester backbone of the AP site is cut at the 5′end of the sugar by the 
action of the AP endonuclease enzyme. This in turn leaves behind a 3′-
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hydorxyl group and a deoxyribose phosphate group at the 5′end. 
Consequently, the deoxyribose phosphate group is being removed and then 
catalyzed by the action of 2-deoxyribose-5-phosphate lyase which is very 
essential to the amino-end of the βpolymerase. Finally, the βpolymerase is 
responsible for filling up the gaps produced and then gets sealed up by the action 
of the ligase enzyme [13]. Hence, studies have shown that the action of the 
βpolymerase is tightly linked to the action of the ligase [13].  
K. Over-expression of βPolymerase and its Effect on BER 
 As mentioned earlier, genetic stability depends on the presence of low but 
constant levels ofβpolymerase in order to perform its optimal function [14]. 
Hence, elevated and advanced levels of βpolymerase causes genetic instability, 
development of cancer, as well as tumor progression [17]. Recent observations 
have indicated that the over expression of βpolymerase is involved in some 
tumor/cancerous cell lines such as leukemia and ovarian cancer cells [14]. 
Moreover, this over expression would lead to significant increase in 
βpolymerase messenger RNA as well as its translated proteins in some tumor 
cell lines [18]. For instance, βpolymerase was observed to be significantly 10- 
folds higher in breast, colon, and prostate cancer tissues than nearby normal 
cells [17]. Based on all of these findings, it has been hypothesized that the over 
expression of βpolymerase as well as its mRNAs and proteins actually disturb 
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the entire DNA polymerase perfect error free task in some cancer cells; this will 
affect the βpolymerase gap filling process during DNA repair, replication or 
recombination pathways and consequently cause mutations and cancer 
developments [17].  
L. Haploinsufficiency in βpolymerase and its Effect on BER 
 It is fascinating how the mouse model has become the most common and 
reliable model of choice to observe the different elements of mammalian 
development and physiology [19]. Despite the fact that mouse models are 
becoming cheaper and easier to apply on, it is actually the ability to genetically 
modify and change the mouse’s genome is what makes it one of the most 
dominant resource available for science research. One way to study the effect of 
the DNA polymerase β on the base excision repair pathway is to genetically 
manipulate the gene encoding this DNA polymerase. For this purpose, 
transgenic mice have been generated with a heterozygous germline deletion 
mutation located in the 5’ end of the DNA polymerase βgene. As these 
transgenic mice have been bred, the offspring that represents the homozygous 
βpol deletion mutation never survived beyond 10.5 days of gestation [20]. Data 
has shown that the DNA β-pol heterozygous (β-pol +/-) mice established a 
~50% reduction in the expression of β-pol mRNA and protein [21]. This finding 
supports the observation of a significant reduction in the BER mechanism which 
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is caused by heterozygous β-pol deletion [21,22]. Moreover, aging is also 
considered a main factor in exponentially increasing the risk of cancer [22]. It is 
believed that the accumulated DNA damage produced with the correlation of 
aging increases the risk of cancer development [22]. Interestingly, it is observed 
that only the mammalian β-pol has a significant and specific role in the base 
excision repair mechanism, which it is believed that it is impossible to be 
substituted by any of the α, β and γ DNA polymerases [20]. 
M. Folate Deficiency, Aging, and Base Excision Repair 
 In order to understand the mechanism behind the effect of folate 
deficiency on the development of cancer and tumors, it is important to consider 
the influence of this deficiency on the base excision repair pathway [6,34]. 
Normally, the BER pathway is established by the harmonization of sequenced 
enzymatic actions to repair the damage and eliminate any accumulations of 
intermediate products that may be produced during the process. Folate 
deficiency disturbs the equilibrium and the coordination of the BER by promoting 
the initiation of the process without any further stimulation for the completion of 
repair. This initiation increases the accumulation of strand breaks, uracil, and 
mutations which in turn inhibits the DNA repair process. This abnormal regulation 
of the repair pathway brings on a state of BER deficiency that is observed in  β-
pol +/- mice [23,24]. A recent study has shown that a folate deficient diet have 
established a considerable increase in aberrant crypt foci (ACF) and tumor 
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development in wild type mice that had been previously exposed to a carcinogen 
[24]. On the contrary, a significant reduction in the ACF has been shown in β -
pol haplinsufficient mice with folate deficiency [24]. Hence, folate deficiency is 
assumed to provide a protective approach against tumorigenesis in a BER- 
deficient medium in all tissues when treated with a carcinogen [24,25]. It has 
been believed that there is a tight correlation between folate deficiency, aging, 
and carcinogenesis which might be explained by the increased mutagenesis [25].  
N. The mTOR Signaling Pathway  
 The mammalian target of rapamycin (mTOR) could be influenced by 
multiple factors including some alterations in nutrient transport, energy 
metabolism, protein availabilty, and purine biosynthesis. This signaling pathway 
is interrupted in diseases that disrupt further growth and cause nutrient 
imbalances such as cancer, inborn error diseases, aging, and metabolic 
disorders. Once the mTOR pathway is deregulated, the proliferation of cancer 
cells gets stimulated causing further damage [26]. On the other hand, the 
additional excitement of the following pathway resulting from the excess intake of 
nutrients might be increasing the risk of developing diabetes [26].  
 In certain tumors and cancer stages, the upstream and downstream 
signaling mechanisms of the substrates have a major effect on the mTOR 
pathway [27] (figure 1-3). In normal conditions, AKT controls the cell proliferation 
and endurance, as well as controlling nutrient metabolisms by the proliferation of 
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some proteins [28]. The substrates eIF4E binding protein (4EBP) and S6 Kinase 
1 (S6K1), along with the correlation of mRNAs, help in normalizing the rate of 
protein synthesis by adjusting the initiation and elongation of the mRNA 
translation [26]. The protein 53 (p53), that is responsible in activating the DNA 
repair proteins when the DNA is being damaged, functions as an anti-cancer 
component [29]. Inositol polyphosphate multikinase (IPMK) has been classified 
as an mTOR cofactor and a significant component in stimulating the signaling 
pathway by responding to amino acid levels [30]. Adenosine Monophosphate -
activated kinase (AMPK) has a powerful ability to sense any energy imbalances 
and react to any fluctuations in the AMP; ATP ratio [30]. Poly (ADP-ribose) 
polymerase (PARP) is an enzyme that plays an important role in responding to 
cellular death. This intervention could be involved in DNA transcription and 
repair, as well in the stability of the genome [31]. Hence, it is important to 
examine how the following substrates and proteins participate in the regulation of 
the mTOR signaling pathway in a folate deficient environment.   
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CHAPTER 2 
SPECIFIC AIMS 
 In order to understand the mechanism behind the effect of folate 
deficiency on the development of cancer and tumors, it is important to examine 
the influence of this deficiency on the base excision repair pathway and on the 
mTOR signaling pathway. Once the mTOR pathway is deregulated, the 
proliferation of cancer cells gets stimulated causing further damage. In certain 
tumors and cancer stages, the upstream and downstream signaling mechanisms 
of the substrates have a major effect on the mTOR pathway. We hypothesize 
that dietary folate restriction alters mTOR signaling network in the liver to provide 
protection against cancer in young and old β-pol +/- mice that have been treated 
with a carcinogen.  
The following are the specific aims of the research: 
Specific Aim 1: To examine if folate deficiency provides a protective role in the 
β-pol +/- young and old mice that have been treated with a colon and liver 
carcinogen by measuring the ACF counts per mouse. 
Specific Aim 2: To examine the impact of folate deficiency on the signaling 
mechanisms of the substrates involved in the regulation of the mTOR signaling 
pathway in the β-pol +/- young and old mice that have been treated with a colon 
and liver carcinogen.  
22 
 
 
CHAPTER 3 
METHODS 
A. Animals  
 Experiments were performed in young 4 to 6-month-old C57BL/6-specific 
pathogen-free male mice and mice heterozygous for the DNA polymerase β gene 
(β-pol+/−). All practices performed on animals were in agreement with the National 
Institutes of Health guidelines for the care and use of laboratory animals. Mice 
heterozygous for the DNA polymerase β gene (β-pol+/−) were created in 
Rajewsky's laboratory by deletion of the promoter and the first exon of the β-
pol gene. Homozygous deletion of β-pol results in embryonic lethality, but the 
heterozygous mice survive and seem to be normal and are fertile; there is no 
retardation in food intake, weight gain, or growth rate. All mice were backcrossed 
into C57BL/6 for at least 20 generations. The genotype of the mice was 
determined by Southern blot analysis as described by Cabelof et al. The Wayne 
State University Animal Investigation Committee approved the animal protocol. 
Mice were maintained on a 12-h light/dark cycle and given water ad libitum [34]. 
B. Diets and Carcinogenic Treatment  
 After acclimation for 7 days, wild type (WT) and β-pol+/− mice were 
randomly assigned to two dietary groups: a folate-adequate (FA) or folate-
deficient (FD) AIN93G-purified isoenergetic diet (Dyets, Inc., Lehigh Valley, PA) 
as described previously. The FA group received a folate-adequate diet containing 
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2 mg/kg of folic acid. The FD group received a folate-deficient diet containing 0 
mg/kg of folic acid. Diets were stored at −20 °C. 1% succinyl sulfathiazole was 
added to all diets. One week after commencement of food ingestion, randomly 
selected mice from both FA and FD were injected intraperitoneally with 1,2-
dimethylhydrazine HCl (DMH, 30 mg/kg body weight) in 10 mmol/liter of 
NaHCO3 (Fisher Scientific) once a week for 6 weeks. Both food intake and body 
weights were checked twice weekly to monitor for signs of toxicity, e.g. weight 
loss, and the diets continued for 12 weeks. Young animals were 6 weeks old 
when the DMH treatment was initiated; whereas the old animals were 24-26 
months old when the DMH treatment was initiated [34].  
C. Aberrant Colonic Crypt (ACF) Analysis  
 Animals were anesthetized under CO2asphyxiation, the abdominal cavity 
was opened and the colon excised, rinsed with cold phosphate-buffered saline, 
cut longitudinally, and fixed flat overnight in 10% neutral buffered formalin. The 
colonic crypts were stained with 2 g/liter of methylene blue in phosphate-buffered 
saline for 5 min. The number of ACF and aberrant crypts per foci were 
determined by light microscopy at ×10 magnification in a blinded manner [34]. 
D. Western Blot Analysis  
 Western blot analysis was performed using 200 μg of nuclear protein as 
previously described. Upon completion of SDS-PAGE, the region containing the 
protein(s) of interest was excised and prepared for Western blot analysis, 
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whereas the remaining portion of the gel was stained with GelCode blue stain 
reagent (Pierce Biotechnology) to ensure equal protein loading. Western analysis 
was accomplished using affinity purified polyclonal antisera developed against 
mouse β-pol. As an internal control for protein loading, membranes were 
reprobed with anti-Lamin B antibody (Santa Cruz Biotechnology, Santa Cruz, 
CA). The bands were visualized and quantified using a ChemiImagerTM System 
(AlphaInnotech, San Leandro, CA) after incubation in SuperSignal® West Pico 
Chemiluminescent Substrate (Pierce Biotechnology). Data are expressed as the 
integrated density value of the band per μg of protein loaded [34]. 
E. Statistical Analysis 
 Statistical significance between means was determined using “unpaired t-
test”. P values less than 0.05 were considered statistically significant.  
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CHAPTER 4 
FIGURES 
Figure 4-1: Experimental Design: WT and β-pol +/- mice were fed either a folate- 
adequate (2 mg/kg, FA) or a folate-deficient (0 mg/kg,FD) diet for a period of 
twelve weeks. All the WT mice in this experiment were young (6 weeks old) when 
the carcinogenic treatment started. Whereas, there were two different groups of 
the β-pol +/- mice that were fed a FD diet, one of which were young (6 weeks old) 
and the others were old animals (24-26 months old) when the carcinogenic 
treatment was first initiated. After the first week of following the respective diets, 
all groups followed the same treatment and were injected with a 30 mg/kg body 
weight of 1,2 dimethylhydrazine (DMH), a colon and liver carcinogen, for a period 
of 6 weeks. After these 6 weeks of consecutive treatments, the animals were 
sacrificed by CO2 asphyxiation on week 12. 
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Figure 4-2: The impact of β-pol +/- on the ACF formation in colon of mice treated 
with DMH. WT (young “Y”) and β-pol +/- (Y or old) received either folate adequate 
(FA) or folate deficient (FD) diet and were subjected to intraperitoneal treatment 
with DMH for 6 weeks at 30 mg/kg body weight. After sacrifice, colons were 
processed as described under “Methods.” Colons were analyzed under light 
microscopy to visualize the number of ACF per mouse colon (ACF/mouse). 
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Figure 4-3: Effect of folate deficiency and DMH treatment on the protein levels of 
p-S6K in the young WT and β-pol +/- mice. This figure represents the analysis of 
the phosphorylated S6K protein levels in mucosa of young (Y) WT and β-pol +/- 
that received either folate adequate (FA) or folate deficient (FD) diet and were 
subjected to either no treatment (control) or intraperitoneal treatment with DMH 
for 6 weeks at 30 mg/kg body weight (DMH). The protein levels were quantified 
using Western blot analysis. Values represent an average (±SEM) of data 
obtained from 3 mice of each group and are representative of separate identical 
experiments. Values with different letter superscripts indicate significant 
differences at p<0.05.  
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Figure 4-4: Effect of folate deficiency and DMH treatment on the protein levels of 
p-4E-BP in the young WT and β-pol +/- mice. This figure represents the analysis 
of the phospohorylated 4E-BP protein levels in mucosa of young (Y) WT and β-
pol +/- that received either folate adequate (FA) or folate deficient (FD) diet and 
were subjected to either no treatment (control) or intraperitoneal treatment with 
DMH for 6 weeks at 30 mg/kg body weight (DMH). The protein levels were 
quantified using Western blot analysis. Values represent an average (±SEM) of 
data obtained from 3 mice of each group and are representative of separate 
identical experiments. Values with different letter superscripts indicate significant 
differences at p<0.05. 
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Figure 4-5: Effect of folate deficiency and DMH treatment on the protein levels of 
p-AKT in the young WT and β-pol +/- mice.This figure represents the analysis of 
the phospohorylated AKT protein levels in mucosa of young (Y) WT and β-pol +/- 
that received either folate adequate (FA) or folate deficient (FD) diet and were 
subjected to either no treatment (control) or intraperitoneal treatment with DMH 
for 6 weeks at 30 mg/kg body weight (DMH). The protein levels were quantified 
using Western blot analysis. Values represent an average (±SEM) of data 
obtained from 3 mice of each group and are representative of separate identical 
experiments. Values with different letter superscripts indicate significant 
differences at p<0.05. 
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Figure 4-6: Effect of folate deficiency and DMH treatment on the protein levels of 
p-AMPK in the young WT and β-pol +/- mice.This figure represents the analysis 
of the phospohorylated AMPK protein levels in mucosa of young (Y) WT and β-
pol +/- that received either folate adequate (FA) or folate deficient (FD) diet and 
were subjected to either no treatment (control) or intraperitoneal treatment with 
DMH for 6 weeks at 30 mg/kg body weight (DMH). The protein levels were 
quantified using Western blot analysis. Values represent an average (±SEM) of 
data obtained from 3 mice of each group and are representative of separate 
identical experiments. Values with different letter superscripts indicate significant 
differences at p<0.05. 
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Figure 4-7: Effect of folate deficiency and DMH treatment on the protein levels of 
IPMK in the young WT and β-pol +/- mice. This figure represents the analysis of 
IPMK protein levels in mucosa of young (Y) WT and β-pol +/- that received either 
folate adequate (FA) or folate deficient (FD) diet and were subjected to either no 
treatment (control) or intraperitoneal treatment with DMH for 6 weeks at 30 mg/kg 
body weight (DMH). The protein levels were quantified using Western blot 
analysis. Values represent an average (±SEM) of data obtained from 3 mice of 
each group and are representative of separate identical experiments. Values with 
different letter superscripts indicate significant differences at p<0.05. 
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Figure 4-8: Effect of folate deficiency and DMH treatment on the cleavage of 
PARP in the young WT and β-pol +/- mice.This figure represents the analysis of 
PARP cleavage in mucosa of young (Y) WT and β-pol +/- that received either 
folate adequate (FA) or folate deficient (FD) diet and were subjected to either no 
treatment (control) or intraperitoneal treatment with DMH for 6 weeks at 30 mg/kg 
body weight (DMH).The cleavage was quantified using Western blot analysis. 
Values represent an average (±SEM) of data obtained from 3 mice of each group 
and are representative of separate identical experiments. Values with different 
letter superscripts indicate significant differences at p<0.05. 
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Figure 4-9: Effect of folate deficiency and DMH treatment on the protein levels of 
P53 in the young WT and β-pol +/- mice. This figure represents the analysis of 
P53 protein levels in mucosa of young (Y) WT and β-pol +/- that received either 
folate adequate (FA) or folate deficient (FD) diet and were subjected to either no 
treatment (control) or intraperitoneal treatment with DMH for 6 weeks at 30 mg/kg 
body weight (DMH).The protein levels were quantified using Western blot 
analysis. Values represent an average (±SEM) of data obtained from 3 mice of 
each group and are representative of separate identical experiments. Values with 
different letter superscripts indicate significant differences at p<0.05. 
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Figure 4-10: Effect of folate deficiency and DMH treatment on the protein levels 
of p-4E-BP in the young and old β-pol +/- mice. This figure represents the 
analysis of the phospohorylated 4E-BP protein levels in mucosa of (young “Y”) 
WT and (Y or old) β-pol +/- that received either folate adequate (FA) or folate 
deficient (FD) diet and were subjected to either no treatment (control) or 
intraperitoneal treatment with DMH for 6 weeks at 30 mg/kg body weight 
(DMH).The protein levels were quantified using Western blot analysis. Values 
represent an average (±SEM) of data obtained from 3 mice of each group and 
are representative of separate identical experiments. Values with different letter 
superscripts indicate significant differences at p<0.05. 
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Figure 4-11: Effect of folate deficiency and DMH treatment on the protein levels 
of p-AKT in the young and old β-pol +/- mice. This figure represents the analysis 
of the phospohorylated AKT protein levels in mucosa of (young “Y”) WT and (Y 
or old) β-pol +/- that received either folate adequate (FA) or folate deficient (FD) 
diet and were subjected to either no treatment (control) or intraperitoneal 
treatment with DMH for 6 weeks at 30 mg/kg body weight (DMH).The protein 
levels were quantified using Western blot analysis. Values represent an average 
(±SEM) of data obtained from 3 mice of each group and are representative of 
separate identical experiments. Values with different letter superscripts indicate 
significant differences at p<0.05. 
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Figure 4-12: Effect of folate deficiency and DMH treatment on the protein levels 
of IPMK in the young and old β-pol +/- mice. This figure represents the analysis 
of IPMK protein levels in mucosa of (young “Y”) WT and (Y or old) β-pol +/- that 
received either folate adequate (FA) or folate deficient (FD) diet and were 
subjected to either no treatment (control) or intraperitoneal treatment with DMH 
for 6 weeks at 30 mg/kg body weight (DMH).The protein levels were quantified 
using Western blot analysis. Values represent an average (±SEM) of data 
obtained from 3 mice of each group and are representative of separate identical 
experiments. Values with different letter superscripts indicate significant 
differences at p<0.05. 
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Figure 4-13: Effect of folate deficiency and DMH treatment on the cleavage of 
PARP in the young and old β-pol +/- mice. This figure represents the analysis of 
PARP cleavage in mucosa of (young “Y”) WT and (Y or old) β-pol +/- that received 
either folate adequate (FA) or folate deficient (FD) diet and were subjected to 
either no treatment (control) or intraperitoneal treatment with DMH for 6 weeks at 
30 mg/kg body weight (DMH).The cleavage was quantified using Western blot 
analysis. Values represent an average (±SEM) of data obtained from 3 mice of 
each group and are representative of separate identical experiments. Values with 
different letter superscripts indicate significant differences at p<0.05. 
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Figure 4-14: Effect of folate deficiency and DMH treatment on the protein levels 
of P53 in the young and old β-pol +/- mice. This figure represents the analysis of 
P53 protein levels in mucosa of (young “Y”) WT and (Y or old) β-pol +/- that 
received either folate adequate (FA) or folate deficient (FD) diet and were 
subjected to either no treatment (control) or intraperitoneal treatment with DMH 
for 6 weeks at 30 mg/kg body weight (DMH).The protein levels were quantified 
using Western blot analysis. Values represent an average (±SEM) of data 
obtained from 3 mice of each group and are representative of separate identical 
experiments. Values with different letter superscripts indicate significant 
differences at p<0.05. 
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CHAPTER 5 
RESULTS/ DISCUSSION 
 Previous studies have shown that there is a tight correlation between 
folate deficiency, aging, and carcinogenesis which might be explained by the 
increased mutagenesis. The base excision repair pathway (BER) is understood 
to sustain the genomic stability by repairing the endogenous DNA damage and 
damages induced by oxidizing and alkylating agents. Any changes in the BER 
homeostasis create an increase in the genomic instability, which has been 
associated with carcinogenesis. Folate deficiency has shown to induce the 
development of cancer by interrupting the BER pathway. It is important to 
understand the effect of folate deficiency and aging on the progression of tumors 
in the liver of DNA polymerase β haploinsufficient (β-pol +/-) mice treated with a 
carcinogen. An experimental design has been developed in our laboratory in 
order to elucidate that folate restriction provides a protective action on 
tumorigenesis with old DNA β-pol +/- mice in response to a carcinogen treatment. 
Wild type (WT) and β-pol+/- mice were given either a folate adequate (2mg/kg, 
FA) or a folate deficient diet (0mg/kg, FD) for a period of twelve weeks (figure 4-
1). All the WT mice in this experiment were young (6 weeks old) when the 
carcinogenic treatment started; whereas, there were two different groups of the 
β-pol +/- mice that were fed a FD diet, one of which were young (6 weeks old) 
and the others were old animals (24-26 months old) when the carcinogenic 
treatment was first initiated. After the first week of following the respective diets, 
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all groups followed the same treatment and were injected with a 30 mg/kg body 
weight of 1,2 dimethylhydrazine (DMH), a colon and liver carcinogen, for a period 
of 6 weeks. After these 6 weeks of consecutive treatments, the animals were 
sacrificed by CO2 asphyxiation on week 12. After these animals were sacrificed, 
the abdominal cavity was opened and the colon was removed and handled 
properly in order to analyze the number of Aberrant Colonic Crypt (ACF). Figure 
(4-2) illustrates the ACF count visualized per mouse colon (ACF/mouse) after the 
colons were analyzed under light microscopy. Previous studies have found that 
untreated WT and β-pol +/-mice did not show any ACF in their colon [34]. This 
finding proved the fact that β-pol +/- mice with a deficiency in the BER capacity 
were unable to stimulate ACF in mice without any DMH treatment. This indicates 
that the DMH treatment promotes the induction of ACF. Folate deficiency 
resulted in a significant increase (~50%) in ACF formation in young WT animals 
treated with DMH as compared with the FA counterpart (figure 4-2). This 
indicates that folate deficiency leads to a significant increase in colon carcinogen 
in response to DMH [34].  Moreover, the figure clearly indicates a significant 
decline (~43%) in the formation of ACF in β-pol +/- mice when being compared to 
their WT counterparts with a FD diet. This finding indicates that the development 
of ACF is lessened in treated- β-pol +/- mice when folate is deficient. After these 
findings, it is interesting to examine the effect of age, along with folate deficiency, 
on the development of ACF in the colons of treated- β-pol +/- mice. Figure (4-2) 
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indicates a dramatic increase (60%) in ACF counts in treated- β-pol +/- old mice 
consuming a folate deficient diet as compared to their young counterparts. This 
finding anticipates that age does display a dramatic development of colon 
carcinogenesis in treated- β-pol +/- mice when folate is deficient. However, a 
significant difference is found in their FA counterparts. This indication should not 
be considered due to the fact that the FA treated- β-pol +/- old mice were not 
able to sustain more than 3 doses of DMH like the rest of the groups. This finding 
indicates that the treated- β-pol +/- old mice were able to sustain the entire 
treatment when folate was deficient. Thus, it is anticipated that folate deficiency 
provides a protective role in treated- β-pol +/- old mice, despite the dramatic 
increase in the development of ACF. 
 Data from our lab, microarray analysis, have observed the effect of folate 
deficiency on the expression of the mammalian target of rapamycin (mTOR) 
signaling pathway in the colon of the young β-pol+/- mice that were treated with 
DMH. The mTOR pathway (figure 1-3) incorporates both intracellular and 
extracellular signals and plays an important role in the regulation of cell growth, 
proliferation and survival. It has been shown that this pathway is triggered during 
several cellular processes (such as: tumor development, adipogenesis, and 
insulin resistance) and is deregulated in the conditions of cancer and type 2 
diabetes [26]. Interestingly, the mTOR pathway was observed to be altered in the 
young animals. Based on these findings, it is interesting to observe the 
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mechanism behind the mTOR signaling pathway on other tissues of the body, 
example liver cells, of the same mice models described earlier.  
 In order to provide a clear comparison of the upstream and downstream 
signaling mechanisms of the substrates involved in the regulation of the mTOR 
pathway, figures (4-3 through 4-9) will provide a comparison between the 
different groups of the young mice. Whereas, figures (4-10 through 4-14) will 
provide the same findings found in figures (4-3 through 4-9) in addition to the 
DMH treated β-pol +/- old mice group that was fed a folate deficient diet.  
 The mTOR complex 1 (mTORC1) controls the synthesis of protein, which 
is necessary for cell growth, via various downstream factors. This protein 
synthesis is normally promoted by the phosphorylation of S6 kinase (S6K-P) and 
4E binding protein (4E-BP). Figure (4-3) illustrates the effect of folate deficiency 
and DMH treatment on the protein levels of p-S6K in the young WT and β-pol +/- 
mice. The figure shows an insignificant difference in the phosphorylation levels of 
S6K protein in both treated and untreated WT young mice when consuming a FA 
diet. However, a significant increase of approximately 46% in the phosphorylation 
of S6K protein has been reported in young WT mice that were treated with DMH, 
in an FD environment compared to their FA counterparts. Interestingly, this level 
drops significantly (~50%) in the young β-pol +/- mice that were treated with 
DMH, when folate was deficient. Similarly, the levels of 4E-BP phosphorylation 
(figure 4-4) did not show any significant difference in treated and untreated WT 
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young mice, consumed a folate adequate diet. Whereas, 4E-BP levels of 
phosphorylation dropped significantly (~60%) in young, treated WT mice when 
folate was deficient, compared to their FA counterparts. No significant difference 
was observed in their β-pol +/- counterparts.  Hence, folate restriction could 
possibly lead to a decline in the activation of mTORC1, which attenuates the 
activation of S6K and the inhibition of 4E-BP. This action could alter the protein 
synthesis, proliferation, and cell growth.   
 Under normal conditions, AKT (aka protein B kinase) controls the cell 
proliferation and endurance, as well as controlling nutrient metabolisms by the 
proliferation of some proteins [28]. The growth factors (such as insulin) stimulate 
the mTORC1 which in turn promotes the phosphorylation of the TSC2 by the 
activation of AKT. Moreover, adenosine monophosphate -activated kinase 
(AMPK) has a powerful ability to sense any energy imbalances and react to any 
fluctuations in the AMP; ATP ratio [30]. The levels of AKT and AMPK protein, 
(figures 4-5 and 4-6 respectively) observed almost similar patterns. An 
insignificant increase in the phosphorylation of AKT and AMPK has been 
indicated in the treated and untreated young WT animal with an FA diet and 
treated WT young mice with folate deficiency. However, a significant decrease 
(~66%) in the phosphorylation of AKT, along with a 50% reduction in the 
phosphorylation of AMPK, is shown with the treated young β-pol +/- mice when 
folate was deficient, compared to their young counterparts. Hence, folate 
58 
 
 
restriction attenuates the activation of AKT and alters the AMPK phosphorylation 
resulting in the inhibition of the mTORC1 pathway. 
 Inositol polyphosphate multikinase (IPMK) has been classified as an 
mTOR cofactor and a significant component in stimulating the signaling pathway 
by responding to amino acid levels [30]. Figure (4-7) indicates that the level of 
IPMK expression is slightly highest among the untreated young WT mice when 
folate was adequate. A ~33% reduction in the expression is indicated in the other 
groups, ultimately reducing mTOR activation.  
 The protein 53 (p53), that is responsible for activating the DNA repair 
proteins when the DNA is being damaged, functions as an anti-cancer 
component [29]. Poly (ADP-ribose) polymerase (PARP) is an enzyme that plays 
an important role in responding to cellular death. The alterations in the levels of 
p53 expression and in the cleavage of PARP are marks of apoptosis. Figure (4-
8) shows that the PARP cleavage is higher (~37%) in untreated young WT than 
in the treated ones, when consuming a folate adequate diet.  These levels are 
higher in treated WT young mice consuming a folate deficient diet. A significant 
reduction (~53%) is shown in their β-pol +/- counterparts. Figure (4-9) indicates 
that there is a slight increase in the level of P53 expression in the treated young 
WT mice in comparison with the untreated mice when consuming a FA diet. 
However, a 20-25% increase is indicated in the animals that were following a FD 
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diet. These findings indicate that there has been a deregulation in the apoptotic 
pathway in the liver of young animals.   
 Figures (4-10 through 4-14) compare the β-pol +/- old mice that were 
treated with DMH when consuming a FD diet with their young counterparts. 
Figures (4-10, 4-11, and 4-12) indicate insignificant change in the levels of p-4E-
BP, p-AKT, and IPMK protein expression in the β-pol +/- old mice treated with 
DMH and consuming a FD diet compared to their young counterparts. However a 
slight decrease in the PARP cleavage and a significant increase in P53 
expression are found in treated β-pol +/- old mice consuming FD diet as 
compared to their young counterparts (Figures4-13 and 4-14). Thus, these 
findings confirm the fact that apoptosis is being significantly altered. We actually 
see differential patterns with different factors, thus further experiments are 
needed in order to more understand the mechanism behind the folate deficiency 
and aging on the liver of β-pol+/- mice, when treated with a carcinogens. 
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CHAPTER 6 
CONCLUSION 
 Several studies have indicated that there is a strong correlation between 
folate deficiency, aging, and carcinogenesis which might be explained by the 
increased mutagenesis and tumorigenesis. It is significant to comprehend the 
effect of folate deficiency and aging on the progression of tumors in the liver of 
β-pol +/- mice treated with a carcinogen. Previous studies have found that WT 
and β-pol +/- mice, that were untreated with DMH, did not show any ACF in their 
colon. However, folate deficiency resulted in a significant increase in ACF 
formation in young WT animals treated with DMH as compared with the FA 
counterpart. This finding indicates that folate deficiency leads to a significant 
increase in colon carcinogen in response to DMH. However, our data clearly 
demonstrated that the development of ACF is lessened in treated- β-pol +/- mice 
when folate is deficient. After these findings, it is interesting to examine the effect 
of age, along with folate deficiency, on the development of ACF in the colon of 
treated- β-pol +/- mice. We have anticipated that age does display a dramatic 
development of colon carcinogenesis in treated- β-pol +/- mice when folate is 
deficient. However, FD may have exerted an anti-cancer protective role to 
treated- β-pol +/- old mice since they were able to sustain the entire treatment, 
unlike their FA counterparts. 
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 Previous studies in our lab have studied the effect of folate deficiency on 
the mTOR signaling pathway in the colon of the young β-pol+/- mice that were 
treated with DMH. These findings increased our curiosity to examine the 
mechanism behind the mTOR signaling pathway on other tissues of the body, 
example liver cells, of the same mice models described earlier.  Our experiments 
indicate that there has been a modulation in the signaling of mTOR pathway in 
the liver of young and old animals. This indicates that apoptosis is being 
significantly altered. Therefore, folate deficiency might have a protective role in 
the β-pol +/- young and old mice that have been treated with a colon and liver 
carcinogen. However, our studies are insufficient and need further studies to 
more understand the mechanism behind the folate deficiency and aging on the 
liver of β-pol+/-, when treated with a carcinogens.  
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ABSTRACT 
EFFECT OF FOLATE DEFICIENCY AND AGING ON mTOR SIGNALING 
NETWORK IN THE LIVER OF DNA POLYMERASE  HAPLOINSUFFICIENT 
MICE   
by 
AMANDA ARRABI 
August 2013 
Advisor: Dr. Ahmad R. Heydari 
Major: Nutrition and Food Science 
Degree: Masters of Science 
 The interaction between the dietary nutrients and the human genome 
causes some alterations in the molecular pathways that could significantly impact 
the development of cancer. The main approach to such concerns is to closely 
observe how the diet modifies the gene expressions that control several cellular 
processes in the human body. Folate deficiency (FD) has established an 
important role in modulating the base excision repair homeostasis altering the 
development of tumors and cancer. We anticipate that age and FD may have 
exerted an anti-cancer protective role in DNA polymerase β haploinsufficient 
(β-pol+/-) mice that are treated with a carcinogen. We hypothesize that dietary 
folate restriction alters mTOR signaling network in the liver to provide protection 
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against cancer in β-pol +/- young and old mice that have been treated with a 
carcinogen.  
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